NOVOPROTEIN

Novoprotein Scientific Inc. (Novoprotein) is a high-tech enterprise with more than 10 years of extensive experience in the recombinant protein industry, focusing on protein technology, and advanced in R&D, production, sales, and application solutions to raw materials and techniques for biopharmaceuticals, in vitro diagnosis, mRNA vaccines, and basic life science research. Our principal products include target proteins and cytokines, recombinant antibodies, molecular enzymes and reagents, as well as providing related technical services. Novoprotein possesses R&D and manufacturing bases in Shanghai, Suzhou, and Heze. We have developed more than ten thousand of recombinant proteins and have independently researched and developed 7...

Mrna,cell and gene therapy,cytokines,organoid,target protein,enzymes,recombinant antibodies,cgt,t7 rna polymerse,gene editing,diagnostic antigen,diagnostic antibodies,diagnostic enzymes and mastermix,lamp,cas9,dsrna detection,adc,cut&tag,atac-seq,service,cro,and cdmo

Novoprotein operates in the Biotechnology research industry.

Novoprotein's revenue is 11m - 100m

Novoprotein has 11 - 50 employees.